7/23/2009

Canadian researchers said they identified genetic variations in thrombomodulin, a protein that plays a role in blood coagulation and preventing cell damage, that appear to increase the risk of atypical hemolytic-uremic syndrome. The findings could pave the way for treatments for aHUS, a rare blood vessel disorder caused by damage to endothelial cells, the lead researcher said.

Related Summaries